-
-
Toggle navigation
Frontiers journals are at the top of citation and impact metrics
in Psychiatry |
|
Submit your manuscript
Scope
The section is aimed at publishing high quality research in all fields of psychopharmacology. Special attention is given to affective and substance use disorders, stress-related disturbances, emotion, cognition and impulse-related pathologies.
Scope
The section is aimed at publishing high quality research in all fields of psychopharmacology. Special attention is given to affective and substance use disorders, stress-related disturbances, emotion, cognition and impulse-related pathologies. We are interested to receive publications from all areas of preclinical and clinical research. One of the primary missions of this section is to promote research aimed at the characterization of novel biological targets and development of new medication for the treatment of CNS disorders. Also relevant to the section are studies aimed at investigating behavioural and neuronal mechanisms associated with psychiatric disease and to understand their molecular, genetic and epigenetic basis. This section additionally covers aspects associated with gender differences in neuropsychiatric pathologies and drug response.
Our ultimate aim is to contribute to improve human health and to enhance the quality of life by promoting research in psychopharmacology.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, PsycINFO, EMBASE, Science Citation Index Expanded, CLOCKSS, Social Science Citation Index
PMCID: all published articles receive a PMCID
Psychopharmacology welcomes submissions of the following article types: Brief Research Report, Case Report, Clinical Trial, Correction, Editorial, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge and Systematic Review.
All manuscripts must be submitted directly to the section Psychopharmacology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Psychopharmacology will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Psychiatry.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact psychiatry.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact psychiatry@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org